These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17322487)

  • 1. Decrease of fructosamine levels during treatment with adalimumab in patients with both diabetes and rheumatoid arthritis.
    van Eijk IC; Peters MJ; Nurmohamed MT; van Deutekom AW; Dijkmans BA; Simsek S
    Eur J Endocrinol; 2007 Mar; 156(3):291-3. PubMed ID: 17322487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of type 1 diabetes mellitus in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor alpha.
    Richez C; Blanco P; Gin H; Schaeverbeke T
    Clin Exp Rheumatol; 2006; 24(5):607. PubMed ID: 17181936
    [No Abstract]   [Full Text] [Related]  

  • 3. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
    Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
    J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-TNFalpha therapy--killing two birds with one stone?
    Arif S; Cox P; Afzali B; Lombardi G; Lechler RI; Peakman M; Mirenda V
    Lancet; 2010 Jun; 375(9733):2278. PubMed ID: 20609973
    [No Abstract]   [Full Text] [Related]  

  • 5. Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis.
    Radstake TR; Svenson M; Eijsbouts AM; van den Hoogen FH; Enevold C; van Riel PL; Bendtzen K
    Ann Rheum Dis; 2009 Nov; 68(11):1739-45. PubMed ID: 19019895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study.
    Peters MJ; Welsh P; McInnes IB; Wolbink G; Dijkmans BA; Sattar N; Nurmohamed MT
    Ann Rheum Dis; 2010 Jul; 69(7):1281-5. PubMed ID: 19934107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNFalpha therapy.
    Rosenvinge A; Krogh-Madsen R; Baslund B; Pedersen BK
    Scand J Rheumatol; 2007; 36(2):91-6. PubMed ID: 17476613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of TNFalpha blockade therapy on circulating adiponectin levels in patients with autoimmune disease: results from two independent prospective studies.
    Peters MJ; Watt P; Cherry L; Welsh P; Henninger E; Dijkmans BA; McInnes IB; Nurmohamed MT; Sattar N
    Ann Rheum Dis; 2010 Sep; 69(9):1687-90. PubMed ID: 19640853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine.
    Gremese E; Carletto A; Padovan M; Atzeni F; Raffeiner B; Giardina AR; Favalli EG; Erre GL; Gorla R; Galeazzi M; Foti R; Cantini F; Salvarani C; Olivieri I; Lapadula G; Ferraccioli G;
    Arthritis Care Res (Hoboken); 2013 Jan; 65(1):94-100. PubMed ID: 22730143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peripheral mononuclear cells and cytokine circulating levels during adalimumab therapy in patients with rheumatoid arthritis].
    Benucci M; Li Gobbi F; Fossi F; Cammelli E; Manfredi M
    Recenti Prog Med; 2005 Sep; 96(9):424-7. PubMed ID: 16229322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adalimumab (Humira)--efficacy in rheumatoid arthritis treatment with particular reference to working ability].
    Grazio S
    Reumatizam; 2008; 55(2):62-7. PubMed ID: 19024278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotic syndrome as a complication of anti-TNFalpha in a patient with rheumatoid arthritis.
    den Broeder AA; Assmann KJ; van Riel PL; Wetzels JF
    Neth J Med; 2003 Apr; 61(4):137-41. PubMed ID: 12852723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of interleukin 7 activity and levels on tumour necrosis factor alpha blockade in patients with rheumatoid arthritis.
    van Roon JA; Hartgring SA; Wenting-van Wijk M; Jacobs KM; Tak PP; Bijlsma JW; Lafeber FP
    Ann Rheum Dis; 2007 May; 66(5):664-9. PubMed ID: 17185327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3.
    Sarzi-Puttini P; Atzeni F; Schölmerich J; Cutolo M; Straub RH
    Ann Rheum Dis; 2006 Mar; 65(3):301-5. PubMed ID: 16079165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial.
    Burmester GR; Mariette X; Montecucco C; Monteagudo-Sáez I; Malaise M; Tzioufas AG; Bijlsma JW; Unnebrink K; Kary S; Kupper H
    Ann Rheum Dis; 2007 Jun; 66(6):732-9. PubMed ID: 17329305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculous peritonitis in a patient with rheumatoid arthritis treated with adalimumab.
    Gutiérrez-Macías A; Lizarralde-Palacios E; Martínez-Odriozola P; Miguel-de la Villa F
    Clin Rheumatol; 2007 Mar; 26(3):452-3. PubMed ID: 16404496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fully human anti TNF-alpha monoclonal antibodies (adalimumab, golimumab)].
    Hirohata S
    Nihon Rinsho; 2007 Jul; 65(7):1202-8. PubMed ID: 17642233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased prevalence of allergic sensitisation in rheumatoid arthritis patients treated with anti-TNFalpha.
    Machado P; Santos A; Pereira C; Loureiro C; Silva J; Chieira C; Malcata A
    Joint Bone Spine; 2009 Oct; 76(5):508-13. PubMed ID: 19467899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors.
    Iannone F; Gremese E; Atzeni F; Biasi D; Botsios C; Cipriani P; Ferri C; Foschi V; Galeazzi M; Gerli R; Giardina A; Marchesoni A; Salaffi F; Ziglioli T; Lapadula G;
    J Rheumatol; 2012 Jun; 39(6):1179-84. PubMed ID: 22467933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.